sclerosing cholangitis: A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.
| Name | K11_CHOLANGI_STRICT |
|---|---|
| Long name | Cholangitis (primary sclerosing, PSC), with reimbursement 202 |
| Hospital Discharge registry | ICD-10: K830, ICD-8: 5750[4-5] |
| Cause of Death registry | ICD-10: K830, ICD-8: 5750[4-5] |
| Conditions required | K11_REIMB_202 |
| First defined in version | DF3 |
| Latin name | Cholangitis |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 238 | 134 | 104 |
| Unadjusted prevalence (%) | 0.11 | 0.11 | 0.11 |
| Mean age at first event (years) | 42.88 | 45.68 | 39.28 |
| Case fatality at 5-years (%) | 2.10 | 2.24 | 1.92 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | 40.36 | 38.65 | 42.18 |
before Cholangitis (primary sclerosing, PSC), with reimbursement 202
after Cholangitis (primary sclerosing, PSC), with reimbursement 202
Loading survival analyses plot…
Loading survival analyses table…